UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease

Leukemia, 2012-06, Vol.26 (6), p.1410-1413

2012

Volltextzugriff (PDF)

Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers

Current medicinal chemistry, 2006-08, Vol.13 (20), p.2345

2006

Volltextzugriff (PDF)

Potentiodynamic anodizing of aluminum alloys in Cr(VI)-free electrolytes

Surface and interface analysis, 2016-08, Vol.48 (8), p.946-952

2016

Volltextzugriff (PDF)

Influence of NaCl on the Behavior of PEO−PPO−PEO Triblock Copolymers in Solution, at Interfaces, and in Asymmetric Liquid Films

Langmuir, 2005-05, Vol.21 (11), p.4954-4963

2005

Volltextzugriff (PDF)

WT1 as a novel target antigen for cancer immunotherapy

Current cancer drug targets, 2002-03, Vol.2 (1), p.45

2002

Volltextzugriff (PDF)

Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product

Immunogenetics (New York), 2000-02, Vol.51 (2), p.99-107

2000

Volltextzugriff (PDF)

Th1-biased humoral immune responses against wilms tumor gene WT1 product in the patients with hematopoietic malignancies

Leukemia, 2005-02, Vol.19 (2), p.268-274

2005

Volltextzugriff (PDF)

Cancer Immunotherapy Targeting Wilms' Tumor Gene WT1 Product

The Journal of immunology (1950), 2000-02, Vol.164 (4), p.1873-1880

2000

Volltextzugriff (PDF)

Novel electrochemical approach to study corrosion mechanism of Al-Au wire-bond pad interconnections

Corrosion engineering, science and technology, 2013-09, Vol.48 (6), p.409-417

2013

Volltextzugriff (PDF)

Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination

Journal of clinical immunology, 2000-05, Vol.20 (3), p.195-202

2000

Volltextzugriff (PDF)

Constitutive expression of the Wilms’ tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)

Leukemia research, 1999-05, Vol.23 (5), p.499-505

1999

Volltextzugriff (PDF)

WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer: Report of Two Cases

Microbiology and immunology, 2004-01, Vol.48 (3), p.175-184

2004

Volltextzugriff (PDF)

Induction of WT1 (Wilms' Tumor Gene)-Specific Cytotoxic T Lymphocytes by WT1 Peptide Vaccine and the Resultant Cancer Regression

Proceedings of the National Academy of Sciences - PNAS, 2004-09, Vol.101 (38), p.13885-13890

2004

Volltextzugriff (PDF)

Effect of vaccination of leukemia patients with a MHC class I peptide of Wilms tumor gene 1 (WT1) peptide with unspecific T helper stimulation on WT1-specific IgM responses and on IgG responses

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.3054-3054

2008

Volltextzugriff (PDF)

Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis

International journal of hematology, 2003-07, Vol.78 (1), p.56-61

2003

Volltextzugriff (PDF)

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

Blood, 2002-05, Vol.99 (9), p.3272-3279

2002

Volltextzugriff (PDF)

WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone

Cancer Immunology, Immunotherapy, 2004-07, Vol.53 (7), p.617-624

2004

Volltextzugriff (PDF)

Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease

Leukemia, 2012, Vol.26 (6), p.1410-1413

2012

Volltextzugriff (PDF)

Identification and Characterization of a WT1 (Wilms Tumor Gene) Protein-derived HLA-DRB10405-restricted 16-mer Helper Peptide That Promotes the Induction and Activation of WTi-specific Cytotoxic T Lymphocytes

Journal of immunotherapy, 2007-04, Vol.30 (3), p.282-293

2007

Volltextzugriff (PDF)

Computer-Aided Selection of Potential Antihypertensive Compounds with Dual Mechanism of Action

Journal of medicinal chemistry, 2003-07, Vol.46 (15), p.3326-3332

2003

Volltextzugriff (PDF)

Thinning of wetting films formed from aqueous solutions of non-ionic surfactant

Journal of colloid and interface science, 2006-09, Vol.301 (1), p.210-216

2006

Volltextzugriff (PDF)

Proteolytic enzymes in human leukemic lymphoid cells. III. Aminopeptidases, angiotensin-converting enzyme, and its inhibitor in cells of different immunological phenotype

Biochemistry (Moscow), 1999-04, Vol.64 (4), p.448-455

1999

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(21)
Berichte
(1)

Sprache

Englisch
(22)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(14)
Humans
(13)
Immunotherapy
(8)
Wt1 Proteins - Immunology
(8)
Animals
(7)
Biological And Medical Sciences
(7)
Wt1
(7)
Immunology
(6)
Leukemia
(6)
Male
(6)
Medical Sciences
(6)
Peptide Fragments - Immunology
(6)
Female
(5)
Hematology
(5)
Mice
(5)
Oncology
(5)
T-Lymphocytes, Cytotoxic - Immunology
(5)
Wilms' Tumor Gene
(5)
Antineoplastic Agents
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease

Development of WT1 peptide cancer vaccine against hematopoietic malignancies and solid cancers

Potentiodynamic anodizing of aluminum alloys in Cr(VI)-free electrolytes

Influence of NaCl on the Behavior of PEO−PPO−PEO Triblock Copolymers in Solution, at Interfaces, and in Asymmetric Liquid Films

WT1 as a novel target antigen for cancer immunotherapy

Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product

Th1-biased humoral immune responses against wilms tumor gene WT1 product in the patients with hematopoietic malignancies

Cancer Immunotherapy Targeting Wilms' Tumor Gene WT1 Product

Novel electrochemical approach to study corrosion mechanism of Al-Au wire-bond pad interconnections

Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination

Constitutive expression of the Wilms’ tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)

WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer: Report of Two Cases

Induction of WT1 (Wilms' Tumor Gene)-Specific Cytotoxic T Lymphocytes by WT1 Peptide Vaccine and the Resultant Cancer Regression

Effect of vaccination of leukemia patients with a MHC class I peptide of Wilms tumor gene 1 (WT1) peptide with unspecific T helper stimulation on WT1-specific IgM responses and on IgG responses

Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone

Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease

Identification and Characterization of a WT1 (Wilms Tumor Gene) Protein-derived HLA-DRB10405-restricted 16-mer Helper Peptide That Promotes the Induction and Activation of WTi-specific Cytotoxic T Lymphocytes

Computer-Aided Selection of Potential Antihypertensive Compounds with Dual Mechanism of Action

Thinning of wetting films formed from aqueous solutions of non-ionic surfactant

Proteolytic enzymes in human leukemic lymphoid cells. III. Aminopeptidases, angiotensin-converting enzyme, and its inhibitor in cells of different immunological phenotype

Suchergebnisse filtern